• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [21936 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2017     NIHR Health Technology Assessment programme Start2quit: a randomised clinical controlled trial to evaluate the effectiveness and cost-effectiveness of using personal tailored risk information and taster sessions to increase the uptake of the NHS Stop Smoking Services
2002     NIHR Health Technology Assessment programme A systematic review of the effectiveness and cost-effectiveness of metal-on-metal hip resurfacing arthroplasty for treatment of hip disease
2004     NIHR Health Technology Assessment programme Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis
2010     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-a) inhibitors, adalimumab and infliximab, for Crohn's disease
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of management strategies for sciatica: systematic review and economic model
2011     NIHR Health Technology Assessment programme Evaluating meta-ethnography: systematic analysis and synthesis of qualitative research
2013     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No. 150 and part review of technology appraisal No. 118): a systematic review and economic model
2019     NIHR Health Technology Assessment programme Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT
2015     NIHR Health Technology Assessment programme Daclatasvir for treating chronic hepatitis C
2017     NIHR Health Technology Assessment programme Randomised controlled trial and economic analysis of an internet-based weight management programme: POWeR+ (Positive Online Weight Reduction)
2023     NIHR Health Technology Assessment programme Online remote behavioural intervention for tics in 9- to 17-year-olds: the ORBIT RCT with embedded process and economic evaluation
2004     NIHR Health Technology Assessment programme VenUS I: a randomised controlled trial of two types of bandage for treating venous leg ulcers
2009     NIHR Health Technology Assessment programme Continuous positive airways pressure (CPAP) for the treatment of obstructive sleep apnoea/hypopnoea syndrome (OSAHS)
2009     NIHR Health Technology Assessment programme Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation
2010     NIHR Health Technology Assessment programme Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, costeffectiveness and economic analysis
2012     NIHR Health Technology Assessment programme Mode of data elicitation, acquisition and response to surveys: a systematic review
2016     NIHR Health Technology Assessment programme The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trial
2015     NIHR Health Technology Assessment programme Naloxegol for treating opioid-induced constipation
2023     NIHR Health Technology Assessment programme Rates of medical or surgical treatment for women with heavy menstrual bleeding: the ECLIPSE trial 10-year observational follow-up study
2004     NIHR Health Technology Assessment programme Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction
2006     NIHR Health Technology Assessment programme A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery
2009     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model
2009     NIHR Health Technology Assessment programme Endovascular stents for abdominal aortic aneurysms
2010     NIHR Health Technology Assessment programme Chemoprevention of colorectal cancer: systematic review and economic model
2017     NIHR Health Technology Assessment programme Duration of intravenous antibiotic therapy for children with acute osteomyelitis or septic arthritis: a feasibility study
2016     NIHR Health Technology Assessment programme tegrated sensor-augmented pump therapy system [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation
2023     NIHR Health Technology Assessment programme Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
2004     NIHR Health Technology Assessment programme A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme
2006     NIHR Health Technology Assessment programme Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies
2008     NIHR Health Technology Assessment programme Structural brain imaging in first episode psychosis
2009     NIHR Health Technology Assessment programme Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation
2009     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of machine perfusion systems and cold static storage of donated kidneys
2012     NIHR Health Technology Assessment programme Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies
2012     NIHR Health Technology Assessment programme Rituximab for the first-line treatment of stage III–IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation
2016     NIHR Health Technology Assessment programme Intervention Now to Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): a systematic review of intervention effectiveness and cost-effectiveness, and qualitative and realist synthesis of implementation factors and user engagement
2016     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-a) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-a-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn's disease: systematic reviews and economic modelling
2017     NIHR Health Technology Assessment programme The clinical effectiveness of individual behaviour change interventions to reduce risky sexual behaviour after a negative human immunodeficiency virus test in men who have sex with men: systematic and realist reviews and intervention development
2023     NIHR Health Technology Assessment programme Comparison of lotions, creams, gels and ointments for the treatment of childhood eczema: the BEE RCT
2001     NIHR Health Technology Assessment programme A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer
2006     NIHR Health Technology Assessment programme Systematic review and evaluation of methods of assessing urinary incontinence
2009     NIHR Health Technology Assessment programme Clinical and cost effectiveness of epoprostenol, iloprost, bosentan, sitaxentan, and sildenafil for the treatment of pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation
2009     NIHR Health Technology Assessment programme Infliximab for the treatment of adults with psoriasis
2009     NIHR Health Technology Assessment programme Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection
2020     NIHR Health Technology Assessment programme Basic versus biofeedback-mediated intensive pelvic floor muscle training for women with urinary incontinence: the OPAL RCT
2018     NIHR Health Technology Assessment programme Synthesising a clinical Prognostic Rule for Ankle INjuries in the Emergency Department (SPRAINED)
2007     NIHR Health Technology Assessment programme Abatacept for the treatment of refractory rheumatoid arthritis
2009     NIHR Health Technology Assessment programme Zanamivir, oseltamivir and amantadine for the treatment of influenza (an update review of existing guidance)
2011     NIHR Health Technology Assessment programme A randomised controlled trial of post-operative radiotherapy following breast-conserving surgery in a minimum-risk population. Quality of life at 5 years in the PRIME trial
2018     NIHR Health Technology Assessment programme Oral steroids for hearing loss associated with otitis media with effusion in children aged 2 8 years: the OSTRICH RCT
2020     NIHR Health Technology Assessment programme Positron emission tomography to image cerebral neuroinflammation in ischaemic stroke: a pilot study
2017     NIHR Health Technology Assessment programme Autologous chondrocyte implantation in the knee: systematic review and economic evaluation
2023     NIHR Health Technology Assessment programme Posterior cervical foraminotomy versus anterior cervical discectomy for cervical brachialgia: the FORVAD RCT
2009     NIHR Health Technology Assessment programme Lapatinib for the treatment of HER2-overexpressing breast cancer
2009     NIHR Health Technology Assessment programme Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal
2012     NIHR Health Technology Assessment programme Screening for cystic fibrosis-related diabetes: a systematic review
2019     NIHR Health Technology Assessment programme Comparing alternating pressure mattresses and high-specification foam mattresses to prevent pressure ulcers in high-risk patients: the PRESSURE 2 RCT
2018     NIHR Health Technology Assessment programme The potential of alternatives to face-to-face consultation in general practice, and the impact on different patient groups: a mixed-methods case study
2023     NIHR Health Technology Assessment programme Exercise therapy for tendinopathy: a mixed-methods evidence synthesis exploring feasibility, acceptability and effectiveness
2009     NIHR Health Technology Assessment programme Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
2009     NIHR Health Technology Assessment programme Enhanced external counterpulsation for stable angina or heart failure: a systematic review and economic evaluation
2014     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
2016     NIHR Health Technology Assessment programme Which method is best for the induction of labour? A systematic review, network meta-analysis and cost-effectiveness analysis
2017     NIHR Health Technology Assessment programme Preventing blood-borne virus infection in people who inject drugs in the UK: systematic review, stakeholder interviews, psychosocial intervention development and feasibility randomised controlled trial
2023     NIHR Health Technology Assessment programme A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial
2009     NIHR Health Technology Assessment programme Rimonabant for the treatment of overweight and obese people
2009     NIHR Health Technology Assessment programme Non-occupational post-exposure prophylaxis for HIV
2018     NIHR Health Technology Assessment programme UK Lung Cancer Screening Trial (UKLS) - Feasibility study and protocol development
2015     NIHR Health Technology Assessment programme Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling
2017     NIHR Health Technology Assessment programme Provision of information about newborn screening antenatally: a sequential exploratory mixed-methods project
2019     NIHR Health Technology Assessment programme Comprehensive geriatric assessment for frail older people in acute hospitals: the HoW-CGA mixed-methods study.
2009     NIHR Health Technology Assessment programme Infliximab for the treatment of ulcerative colitis
2009     NIHR Health Technology Assessment programme The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation
2008     NIHR Health Technology Assessment programme Rapid systematic review of the impact of participation in research
2016     NIHR Health Technology Assessment programme The effectiveness, acceptability and cost-effectiveness of psychosocial interventions for maltreated children and adolescents: an evidence synthesis
2019     NIHR Health Technology Assessment programme A workplace-based intervention to increase levels of daily physical activity: the Travel to Work cluster RCT
2015     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study)
2016     NIHR Health Technology Assessment programme UNderstanding uptake of Immunisations in TravellIng aNd Gypsy communities (UNITING): a qualitative interview study
2006     NIHR Health Technology Assessment programme The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation
2009     NIHR Health Technology Assessment programme Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation
2015     NIHR Health Technology Assessment programme A study of cellular counting to determine minimum thresholds for adequacy for liquid-based cervical cytology using a survey and counting protocol
2015     NIHR Health Technology Assessment programme Benefits of Incentives for Breastfeeding and Smoking cessation in pregnancy (BIBS): a mixed-methods study to inform trial design
2020     NIHR Health Technology Assessment programme Dementia Care Mapping to reduce agitation in care home residents with dementia: the EPIC cluster RCT
2021     NIHR Health Technology Assessment programme The Arabin pessary to prevent preterm birth in women with a twin pregnancy and a short cervix: the STOPPIT 2 RCT
2023     NIHR Health Technology Assessment programme Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
2004     NIHR Health Technology Assessment programme A systematic review of the role of bisphosphonates in metastatic disease
2006     NIHR Health Technology Assessment programme A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
2009     NIHR Health Technology Assessment programme Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal
2011     NIHR Health Technology Assessment programme Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation
2016     NIHR Health Technology Assessment programme UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
2022     NIHR Health Technology Assessment programme Therapeutic Interventions for Stones of the Ureter (TISU): a multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic retrieval, for ureteric stones
2004     NIHR Health Technology Assessment programme Effectiveness and efficiency of guideline dissemination and implementation strategies
2005     NIHR Health Technology Assessment programme A randomised controlled comparison of alternative strategies in stroke care
2006     NIHR Health Technology Assessment programme Telemedicine in dermatology: a randomised controlled trial
2009     NIHR Health Technology Assessment programme A systematic review of presumed consent systems for deceased organ donation
2011     NIHR Health Technology Assessment programme The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation
2015     NIHR Health Technology Assessment programme Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis
2018     NIHR Health Technology Assessment programme Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST
2020     NIHR Health Technology Assessment programme Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT